NeoGenomics Inc. Common Stock vs iShares 1 3 Year Treasury Bond ETF — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while iShares 1 3 Year Treasury Bond ETF trades at $81.29 (market cap $26.90B). The key difference: iShares 1 3 Year Treasury Bond ETF is far larger — about 12.4× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and iShares 1 3 Year Treasury Bond ETF for 64 Days on average.
| NEO | SHY | |
|---|---|---|
Market Cap | $2.17B | $26.90B |
Volume | 1,615,943 | 3,727,878 |
Sector | Health | Fixed Income |
52-Week High | $19.91 | $83.18 |
52-Week Low | $7.19 | $81.05 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $2.47B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHY trades at $81.19 with minimal daily movement (+0.02%). Technical indicators show a bearish trend with moving averages signaling caution, though oscillators remain neutral. The fund maintains consistent dividend distributions, with recent payouts of $0.24-0.25 per share. Current market conditions reflect broader bond market volatility as Treasury yields reach multi-decade highs.
The short-term bond ETF faces headwinds from rising interest rates but benefits from limited duration risk. Higher yields may attract investors seeking income, though continued bond market volatility poses near-term pressure. The fund's stability and consistent dividends provide defensive characteristics in uncertain rate environments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →